vTv Therapeutics, Inc. Class A
VTVT · NASDAQ · USD
$31.18
+1.10 3.66%todayNot financial advice.
- Open
- 30.16
- Day range
- 30.10 - 31.18
- 52-week range
- 19.50 - 44.00
- Volume
- 12.84K
- Market cap
- 123.29M
- P/E ratio
- —
- EPS
- -0.76
- Dividend yield
- 0.00%
- Beta
- -0.66
Performance
W
−3.17%
1M
−5.49%
3M
−4.33%
6M
−16.43%
YTD
−22.32%
Y
+49.26%
5Y
−50.35%
All
−94.43%
In the news
Oct 10
vTv Therapeutics Shares New Research on Type 1 Diabetes Treatment Burdens at Medical Congress
vTv Therapeutics presented research showing over half of adults with type 1 diabetes using automated insulin systems still face hypoglycemia burdens.
Company news
Oct 7
vTv Therapeutics Receives FDA Orphan Drug Designation for Sickle Cell Disease Treatment
vTv Therapeutics received FDA orphan drug status for its sickle cell candidate HPPD, helping advance partnership discussions for the program.
Company news
Oct 7
vTv Therapeutics Receives FDA Orphan Drug Status for Sickle Cell Treatment
vTv Therapeutics (NASDAQ:VTVT) received FDA orphan drug status for HPPD, a sickle cell disease candidate, boosting its partnering prospects.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-VTVT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="vTv Therapeutics, Inc. Class A (VTVT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-VTVT">VTVT stock price</a> by FreeTheAI Stocks</p>